Bronchopulmonary Dysplasia in Post-Surfactant Era: Results of an Objective Assessment of the Disease
Modern methods of respiratory support have led to the transformation of the course of bronchopulmonary dysplasia. A significant role is played by the use of surfactant preparations for the prevention of respiratory distress syndrome and subsequent formation of bronchopulmonary dysplasia in premature...
| Published in: | Вопросы современной педиатрии |
|---|---|
| Main Authors: | I. V. Davydova, A. V. Anikin, O. V. Kustova, A. V. Sidenko, E. Yu. Basargina, E. V. Pavlyukova, V. K. Pozharishchenskaya |
| Format: | Article |
| Language: | English |
| Published: |
"Paediatrician" Publishers LLC
2015-09-01
|
| Subjects: | |
| Online Access: | https://vsp.spr-journal.ru/jour/article/view/1094 |
Similar Items
Genetic Determination of Bronchopulmonary Dysplasia Formation: Pros and Cons
by: V. K. Pozharishchenskaya, et al.
Published: (2017-05-01)
by: V. K. Pozharishchenskaya, et al.
Published: (2017-05-01)
Intratracheal Administration of Budesonide-instilled Surfactant for Prevention of Bronchopulmonary Dysplasia: A Randomized Controlled Clinical Trial
by: Amir Mohamad Armanian, et al.
Published: (2023-10-01)
by: Amir Mohamad Armanian, et al.
Published: (2023-10-01)
Loss of Surfactant Protein A Alters Perinatal Lung Morphology and Susceptibility to Hyperoxia-Induced Bronchopulmonary Dysplasia
by: Shaili Amatya, et al.
Published: (2024-10-01)
by: Shaili Amatya, et al.
Published: (2024-10-01)
PREVENTIVE STRATEGIES IN THE STAGES OF FORMATION AND COURSE OF BRONCHOPULMONARY DYSPLASIA
by: I. V. Davydova, et al.
Published: (2014-03-01)
by: I. V. Davydova, et al.
Published: (2014-03-01)
A Pathogenic Relationship of Bronchopulmonary Dysplasia and Retinopathy of Prematurity? A Review of Angiogenic Mediators in Both Diseases
by: Ashley Stark, et al.
Published: (2018-06-01)
by: Ashley Stark, et al.
Published: (2018-06-01)
Criteria for the duration of anti-inflammatory therapy in children with bronchopulmonary dysplasia
by: Т. І. Stepanenko, et al.
Published: (2019-04-01)
by: Т. І. Stepanenko, et al.
Published: (2019-04-01)
Analysis of status of preterm infants with bronchopulmonary dysplasia
by: Chernenkov Yu.V., et al.
Published: (2017-06-01)
by: Chernenkov Yu.V., et al.
Published: (2017-06-01)
Evaluation of mediators of fibrosis and angiogenesis in the blood serum of premature infants with bronchopulmonary dysplasia
by: E. L. Semikina, et al.
Published: (2023-06-01)
by: E. L. Semikina, et al.
Published: (2023-06-01)
Treatment and prophylaxis of moderate and severe bronchopulmonary dysplasia in premature neonates
by: A.V. Bolonska, et al.
Published: (2021-09-01)
by: A.V. Bolonska, et al.
Published: (2021-09-01)
A Practical, Evidence-Based Approach to Postneonatal Management of Children with Bronchopulmonary Dysplasia
by: Caroline Poulter, et al.
Published: (2019-07-01)
by: Caroline Poulter, et al.
Published: (2019-07-01)
Bronchopulmonary dysplasia frequency and risk factors in very low birth weight infants: A 3-year retrospective study
by: Turgay Cokyaman, et al.
Published: (2020-03-01)
by: Turgay Cokyaman, et al.
Published: (2020-03-01)
PREDICTIVE CAPABILITY OF NEUROTRACTOGRAPHY IN PREMATURE NEWBORNS WITH LOW AND EXTREMELY LOW BODY WEIGHT WITH MANIFESTING BRONCHOPULMONARY DYSPLASIA
by: M. P. Yakovenko, et al.
Published: (2017-10-01)
by: M. P. Yakovenko, et al.
Published: (2017-10-01)
A Randomized Clinical Trial of Intratracheal Administration of Surfactant and Budesonide Combination in Comparison to Surfactant for Prevention of Bronchopulmonary Dysplasia
by: Manizheh M. Gharehbaghi, et al.
Published: (2021-07-01)
by: Manizheh M. Gharehbaghi, et al.
Published: (2021-07-01)
Meta-analysis of budesonide and surfactant combination for the prevention of bronchopulmonary dysplasia in preterm neonates based on gestational age
by: Sedigheh Ekraminasab, et al.
Published: (2025-04-01)
by: Sedigheh Ekraminasab, et al.
Published: (2025-04-01)
An Innovative Model of Bronchopulmonary Dysplasia in Premature Infants
by: Xiaoyue Zhang, et al.
Published: (2020-05-01)
by: Xiaoyue Zhang, et al.
Published: (2020-05-01)
The Most Important Risk Factors and Associated Morbidities of Bronchopulmonary Dysplasia, the Never Ending Problem of Preterms
by: Ayşen Bayrak, et al.
Published: (2025-08-01)
by: Ayşen Bayrak, et al.
Published: (2025-08-01)
The relationship between eosinophilia and bronchopulmonary dysplasia in premature infants at less than 34 weeks' gestation
by: Joo Yun Yang, et al.
Published: (2014-04-01)
by: Joo Yun Yang, et al.
Published: (2014-04-01)
Intratracheal administration of budesonide with surfactant in very low birth weight infants to prevent bronchopulmonary dysplasia
by: Minji Heo, et al.
Published: (2020-08-01)
by: Minji Heo, et al.
Published: (2020-08-01)
Early prediction of moderate to severe bronchopulmonary dysplasia in extremely premature infants
by: Amit Sharma, et al.
Published: (2020-06-01)
by: Amit Sharma, et al.
Published: (2020-06-01)
Updates on functional characterisation of bronchopulmonary dysplasia – the contribution of lung function testing
by: Anne eGreenough, et al.
Published: (2015-05-01)
by: Anne eGreenough, et al.
Published: (2015-05-01)
Respiratory support strategies in the prevention and treatment of bronchopulmonary dysplasia
by: Erik B. Hysinger, et al.
Published: (2023-03-01)
by: Erik B. Hysinger, et al.
Published: (2023-03-01)
Influence of time under mechanical ventilation on bronchopulmonary dysplasia severity in extremely preterm infants: a pilot study
by: Victoria Escobar, et al.
Published: (2020-05-01)
by: Victoria Escobar, et al.
Published: (2020-05-01)
Effects of less invasive surfactant administration versus intubation-surfactant-extubation on bronchopulmonary dysplasia in preterm infants with respiratory distress syndrome: a single-center, retrospective study from China
by: Chun-cai Xu, et al.
Published: (2022-12-01)
by: Chun-cai Xu, et al.
Published: (2022-12-01)
Efficacy of vibroacoustic therapy in treatment of pneumonia in children with bronchopulmonary dysplasia
by: Madina Syzdykova, et al.
Published: (2023-09-01)
by: Madina Syzdykova, et al.
Published: (2023-09-01)
Bronchopulmonary Dysplasia in Extremely Premature Infants: A Scoping Review for Identifying Risk Factors
by: Masato Ito, et al.
Published: (2023-02-01)
by: Masato Ito, et al.
Published: (2023-02-01)
Where are we now with the role of steroids in the management of bronchopulmonary dysplasia (BPD) in extremely premature babies?
by: MATTHEW HURLEY, et al.
Published: (2016-08-01)
by: MATTHEW HURLEY, et al.
Published: (2016-08-01)
Predictive Value of Eosinophilia and Basophilia in the Diagnosis of Bronchopulmonary Dysplasia in Premature Infants
by: Melek Buyukeren, et al.
Published: (2022-03-01)
by: Melek Buyukeren, et al.
Published: (2022-03-01)
Initial respiratory management in preterm infants and bronchopulmonary dysplasia
by: Ester Sanz López, et al.
Published: (2011-01-01)
by: Ester Sanz López, et al.
Published: (2011-01-01)
Editorial: Bronchopulmonary dysplasia: latest advances
by: Shahana Perveen, et al.
Published: (2023-11-01)
by: Shahana Perveen, et al.
Published: (2023-11-01)
Bronchopulmonary Dysplasia: An Update on Experimental Therapeutics
by: Anika Naeem, et al.
Published: (2019-03-01)
by: Anika Naeem, et al.
Published: (2019-03-01)
New Pharmacologic Approaches to Bronchopulmonary Dysplasia
by: Roberts K, et al.
Published: (2021-03-01)
by: Roberts K, et al.
Published: (2021-03-01)
Respiratory severity score-guided postnatal systemic corticosteroid therapy for bronchopulmonary dysplasia in extremely preterm infants
by: Gyeong Eun Yeom, et al.
Published: (2025-09-01)
by: Gyeong Eun Yeom, et al.
Published: (2025-09-01)
Respiratory-syncytial virus immunoprophylaxis on asthma symptoms development in prematurity with bronchopulmonary dysplasia
by: Li-Ching Fang, MD, et al.
Published: (2023-11-01)
by: Li-Ching Fang, MD, et al.
Published: (2023-11-01)
Incidence and factors associated with bronchopulmonary dysplasia in discharges from Neonatal Intensive Care Units in Northern Minas Gerais
by: Micheline Soares Diniz Menezes, et al.
Published: (2024-10-01)
by: Micheline Soares Diniz Menezes, et al.
Published: (2024-10-01)
Association of Acute Kidney Injury with Bronchopulmonary Dysplasia in Preterm Infants
by: Saime Hacer OZDEMIR, et al.
Published: (2024-09-01)
by: Saime Hacer OZDEMIR, et al.
Published: (2024-09-01)
Bronchoscopic Evaluations in Preterm Infants with Moderate to Severe Bronchopulmonary Dysplasia
by: Min Ji Suh, et al.
Published: (2024-05-01)
by: Min Ji Suh, et al.
Published: (2024-05-01)
A nomogram for predicting the risk of Bronchopulmonary dysplasia in premature infants
by: Xian Shen, et al.
Published: (2023-08-01)
by: Xian Shen, et al.
Published: (2023-08-01)
CCR2 Mediates Chronic LPS-Induced Pulmonary Inflammation and Hypoalveolarization in a Murine Model of Bronchopulmonary Dysplasia
by: Tracy X. Cui, et al.
Published: (2020-10-01)
by: Tracy X. Cui, et al.
Published: (2020-10-01)
Stem-Cell Therapy for Bronchopulmonary Dysplasia (BPD) in Newborns
by: Said A. Omar, et al.
Published: (2022-04-01)
by: Said A. Omar, et al.
Published: (2022-04-01)
A Comparison of the 2022 Versus 2011 National Institute of Child Health and Human Development Web-Based Risk Estimator for Bronchopulmonary Dysplasia
by: Mitchell Kinkor, MD, et al.
Published: (2024-12-01)
by: Mitchell Kinkor, MD, et al.
Published: (2024-12-01)
Similar Items
-
Genetic Determination of Bronchopulmonary Dysplasia Formation: Pros and Cons
by: V. K. Pozharishchenskaya, et al.
Published: (2017-05-01) -
Intratracheal Administration of Budesonide-instilled Surfactant for Prevention of Bronchopulmonary Dysplasia: A Randomized Controlled Clinical Trial
by: Amir Mohamad Armanian, et al.
Published: (2023-10-01) -
Loss of Surfactant Protein A Alters Perinatal Lung Morphology and Susceptibility to Hyperoxia-Induced Bronchopulmonary Dysplasia
by: Shaili Amatya, et al.
Published: (2024-10-01) -
PREVENTIVE STRATEGIES IN THE STAGES OF FORMATION AND COURSE OF BRONCHOPULMONARY DYSPLASIA
by: I. V. Davydova, et al.
Published: (2014-03-01) -
A Pathogenic Relationship of Bronchopulmonary Dysplasia and Retinopathy of Prematurity? A Review of Angiogenic Mediators in Both Diseases
by: Ashley Stark, et al.
Published: (2018-06-01)
